WINT

Windtree Therapeutics
WINT

Delisted

WINT was delisted on the 20th of August, 2025.

Back to rankings

5 hedge funds and large institutions have $57K invested in Windtree Therapeutics in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
5
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$34.7K
2
+$18.9K
3
+$1.62K
4
Bank of America
Bank of America
North Carolina
+$125
5
SS
SBI Securities
Japan
+$29

Top Sellers

1
-$41.7K
2
-$20.7K
3
-$6.8K
4
Two Sigma Investments
Two Sigma Investments
New York
-$5.05K
5
CSS
Cubist Systematic Strategies
Connecticut
-$4.78K
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
1
UBS Group
Switzerland
$36.2K
Morgan Stanley
2
Morgan Stanley
New York
$18.9K
TRCT
3
Tower Research Capital (TRC)
New York
$1.73K
Bank of America
4
Bank of America
North Carolina
$126
SS
5
SBI Securities
Japan
$30
Renaissance Technologies
6
Renaissance Technologies
New York
–
Geode Capital Management
7
Geode Capital Management
Massachusetts
–
XT
8
XTX Topco
Cayman Islands
–
Two Sigma Investments
9
Two Sigma Investments
New York
–
CSS
10
Cubist Systematic Strategies
Connecticut
–
Goldman Sachs
11
Goldman Sachs
New York
–
HF
12
HRT Financial
New York
–
BlackRock
13
BlackRock
New York
–
AWM
14
Activest Wealth Management
Florida
–